Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation - Summary of Stock Option Activity for AutoMD (Details)

v3.4.0.3
Stockholders' Equity and Share-Based Compensation - Summary of Stock Option Activity for AutoMD (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Apr. 02, 2016
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Granted (in shares) 680
Expired (in shares) (10)
Forfeited (in shares) (4)
AMD Plan  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding, beginning balance (in shares) 1,430
Granted (in shares) 10
Exercised (in shares) 0
Expired (in shares) 0
Forfeited (in shares) (35)
Options outstanding, ending balance (in shares) 1,405
Vested and expected to vest, ending balance (in shares) 1,044
Options exercisable, ending balance (in shares) 345
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Options outstanding, weighted average exercise price, beginning balance (in dollars per share) | $ / shares $ 1.00
Granted, weighted average exercise price (in dollars per share) | $ / shares 1.00
Exercised, weighted average exercise price (in dollars per share) | $ / shares 0.00
Expired, weighted average exercise price (in dollars per share) | $ / shares 0.00
Forfeited, weighted average exercise price (in dollars per share) | $ / shares 1.00
Options outstanding, weighted average exercise price, ending balance (in dollars per share) | $ / shares 1.00
Vested and expected to vest, weighted average exercise price ending balance (in dollars per share) | $ / shares 1.00
Options exercisable, weighted average exercise price, ending balance (in dollars per share) | $ / shares $ 1.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Options outstanding, weighted average remaining contractual term (in years) 8 years 11 months 12 days
Vested and expected to vest, weighted average remaining contractual term (in years) 8 years 11 months 9 days
Options exercisable, weighted average remaining contractual term (in years) 8 years 9 months 18 days
Options outstanding, aggregate intrinsic value | $ $ 0
Vested and expected to vest, aggregate intrinsic value | $ 0
Options exercisable, aggregate intrinsic value | $ $ 0